Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis

NCT01532336 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenoviral Conjunctivitis

Interventions

DRUG: NVC-422 Solution, 0.3%
DRUG: NVC-422 Vehicle Solution

Sponsor

NovaBay Pharmaceuticals, Inc.